DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 3056492
» See Plans and Pricing
US Patent Family Members and Approved Drugs for European Patent Office Patent: 3056492
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Nov 20, 2027 | Melinta | BAXDELA | delafloxacin meglumine |
Start Trial | Oct 2, 2026 | Melinta | BAXDELA | delafloxacin meglumine |
Start Trial | Aug 6, 2026 | Melinta | BAXDELA | delafloxacin meglumine |
Start Trial | Oct 7, 2025 | Melinta | BAXDELA | delafloxacin meglumine |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |